Author: <span>Mesothelioma News</span>

Aduro Announces Pancreatic Cancer and Mesothelioma Abstracts to Be…

Aduro BioTech, Inc., a clinical stage biotechnology company, today announced that two posters highlighting clinical trials of the company’s pancreatic cancer and mesothelioma immunotherapies will be presented at the upcoming American Society of Clinica…